IGES acquires majority stake in Synergus RWE – a European Medtech market access specialist

Continuation of its European growth course – Expansion of services for manufacturers of medical devices - Integration of the use of Scandinavian medical registries

Berlin, 5 July 2023 (IGES Institute) – IGES Group continues to expand its consulting services for developers and manufacturers of medical devices. To this end, the IGES Institute has acquired a majority stake in Synergus RWE, a medtech market access specialist from Sweden. The IGES Group is thus also continuing its European expansion and is now represented by subsidiaries in six European countries.

Synergus RWE specialises in the design and execution of market access strategies for medical devices, diagnostics and digital health applications in Europe. The company provides broad methodological expertise and extensive experience in accessing and using medical registries in countries in Northern Europe, with the focus on the generation of real-world evidence (RWE).

“Real-world evidence data in medical registries are becoming increasingly important, and the Scandinavian countries are pioneers in this field. Thanks to our acquisition of Synergus RWE, we will be in a position to open up even more opportunities to generate evidence for our customers in the life sciences industry”, said Bertram Häussler, Chairman of the IGES Management Board. "The acquisition will likewise enable us to provide even more comprehensive cross-border strategies for market access from one source."

Synergus founder, Mattias Kyhlstedt, will continue to steer Synergus RWE as CEO from the company's headquarters in Stockholm. He stressed: "The competencies of IGES and Synergus RWE are an ideal fit and this move will facilitate the further expansion of joint consulting services. We offer the developers of medical innovations support for successful market access and for the entire product lifecycle management of their products.”

About IGES: The Knowledge Corporation - From Information to Innovation

The IGES Institute, founded in 1980, is the core of the IGES group. Today, it is the largest privately-owned research and consulting institution of its kind for health and infrastructure questions. IGES offers creative solutions for questions in care, quality, financing and shaping competition for all actors in the life sciences arena and has conducted over 4,000 research and consulting projects since its foundation. Further members of the IGES Group are several specialized companies in five European countries that primarily provide services to international life science industries.

Synergus RWE – Evidence for Decisions

Synergus RWE supports Medical Device, Diagnostics and Digital Solutions to develop and execute market access strategies across western Europe. This includes services from early advice on required evidence, strategies for market access all the way to supporting dossier submissions. Even though the company is based in Sweden, most of the work is for other countries. Leveraging the unique Real Wold Data sources in Sweden, Synergus RWE also provides Real-World-Evidence studies.”